Thursday, April 13, 2017 8:27:03 PM
Given that:
1. The new Sapetro deal essentially values the concession at $0 (unless you're willing to count the reimbursement of their 50% share of the already sunk $8-10M in well costs). The possibilities of additional farm-outs have apparently dissolved.
2. Hyper has apparently missed the deadline in the Sapetro agreement of April 10 to obtain their portion of the Fatala well cost ($15-20M).
3. There has been no word of any extension or waiver of the deadline to my knowledge.
4. Given that the Sapetro agreement was signed just 11 days before the well cost funding deadline; I can only imagine that RL thought he had the funding lined up at the time of signing (March 30) and something has happened to impact it and/or the timing.
I would expect some news prior to or at the SHM (or it will be be a pretty gruesome affair) & the share price will be impacted.
Why anyone would buy in before the funding/dilution news is beyond me (hard to see how the dilution wont be very significant even if the funding is possible).
JMHO-GLTA
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM